Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-09-14

Clinical Trial Update: Veliparib With Carboplatin and Paclitaxel and as Continuation Maintenance Therapy in Adults With Newly Diagnosed Stage III or IV, High-grade Serous, Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating veliparib with carboplatin/paclitaxel and continuation maintenance in newly diagnosed stage III/IV high-grade serous epithelial ovari…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CARBOPLATIN (Carboplatin)
  • PACLITAXEL (PACLITAXEL)
  • Veliparib (veliparib)

Snippet

Sponsor: AbbVie | Conditions: Ovarian Cancer, Ovarian Neoplasm | Phase 3 | Status: TERMINATED | Results posted: 2020-09-14